CHELSEA CARLAN: Open Payments
NPI 1801563572 · REIDSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 35 payments from 15 companies in 2025. Trend: 2023 $749 · 2024 $1,448 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $236 |
| Madrigal Pharmaceuticals | 3 | $174 |
| Ardelyx, Inc. | 3 | $72 |
| Phathom Pharmaceuticals, Inc. | 4 | $57 |
| Gilead Sciences, Inc. | 1 | $56 |
| QOL Medical, LLC | 2 | $53 |
| Celltrion USA Inc. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $28 |
| Pharmacosmos Therapeutics Inc. | 1 | $27 |
Products named: REZDIFFRA, LINZESS, IBSRELA, CREON, VOQUEZNA, Sucraid, MAVYRET, RINVOQ.
Industry payments across NC — which companies pay providers there.
